D89.833
Cytokine release syndrome, grade 3
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytokine Release Syndrome (CRS) is a condition that can occur when the body's immune system releases an excessive amount of cytokines into the bloodstream. Cytokines are substances produced by immune cells to help fight infections and promote healing. However, in some cases, this immune response becomes overactive, leading to systemic symptoms that can range from mild to severe. Grade 3 CRS signifies a more serious form of this syndrome, requiring attentive medical management. This condition often appears as a side effect of certain immunotherapies used to treat cancer, such as CAR T-cell therapy, but can also be caused by infections or other immune-modulating treatments.
Causes & Symptoms
Clinical Causes: Immunotherapy treatments, especially CAR T-cell therapy Infections that elicit a strong immune response Certain medications that stimulate the immune system Other immune-related disorders
Key Symptoms: High fever Low blood pressure (hypotension) Difficulty breathing or shortness of breath Rapid heart rate (tachycardia) Fatigue and weakness Swelling due to fluid accumulation Organ dysfunction, including liver, kidney, or heart problems Skin rash or redness
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves clinical evaluation of symptoms, recent medical history, and laboratory tests. Blood tests may reveal elevated cytokines, abnormal blood counts, and signs of inflammation. Imaging studies could be used to assess organ involvement. Healthcare providers also consider the context, such as recent immunotherapy treatments or infections, to determine the likelihood of CRS. Grading of CRS severity, as in grade 3, is based on specific clinical criteria, including the impact on organ function and the extent of symptoms.
Treatment Protocols: Supportive care with fluids and oxygen therapy Medications to reduce inflammation, such as corticosteroids Use of cytokine-targeting agents like tocilizumab to block specific cytokines involved in the syndrome Medications to support blood pressure and organ function Adjustment or cessation of immunotherapy treatments, if applicable In severe cases, mechanical support like ventilators or dialysis may be necessary
Clinical Advice & FAQs
Billing Guidance
Is D89.833 a billable ICD-10 code?
Yes, D89.833 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.833?
Clinical documentation must specify the nature of Cytokine release syndrome, grade 3 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference